BIIB logo

Biogen (BIIB) Revenue

Annual revenue:

$9.68B-$159.70M(-1.62%)
December 31, 2024

Summary

  • As of today (April 15, 2025), BIIB annual revenue is $9.68 billion, with the most recent change of -$159.70 million (-1.62%) on December 31, 2024.
  • During the last 3 years, BIIB annual revenue has fallen by -$1.31 billion (-11.89%).
  • BIIB annual revenue is now -32.70% below its all-time high of $14.38 billion, reached on December 31, 2019.

Performance

BIIB Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBincome statement metrics

Quarterly revenue:

$2.45B-$11.10M(-0.45%)
December 31, 2024

Summary

  • As of today (April 15, 2025), BIIB quarterly revenue is $2.45 billion, with the most recent change of -$11.10 million (-0.45%) on December 31, 2024.
  • Over the past year, BIIB quarterly revenue has dropped by -$11.10 million (-0.45%).
  • BIIB quarterly revenue is now -33.33% below its all-time high of $3.68 billion, reached on June 30, 2020.

Performance

BIIB Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBincome statement metrics

TTM revenue:

$9.68B+$68.40M(+0.71%)
December 31, 2024

Summary

  • As of today (April 15, 2025), BIIB TTM revenue is $9.68 billion, with the most recent change of +$68.40 million (+0.71%) on December 31, 2024.
  • Over the past year, BIIB TTM revenue has increased by +$68.40 million (+0.71%).
  • BIIB TTM revenue is now -33.21% below its all-time high of $14.49 billion, reached on June 30, 2020.

Performance

BIIB TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBincome statement metrics

BIIB Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.6%-0.5%+0.7%
3 y3 years-11.9%-0.5%+0.7%
5 y5 years-32.7%-0.5%+0.7%

BIIB Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-11.9%at low-5.2%+7.2%-10.6%+0.7%
5 y5-year-32.7%at low-33.3%+7.2%-33.2%+0.7%
alltimeall time-32.7%>+9999.0%-33.3%+655.7%-33.2%>+9999.0%

Biogen Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$9.68B(-1.6%)
$2.45B(-0.5%)
$9.68B(+0.7%)
Sep 2024
-
$2.47B(+0.0%)
$9.61B(-0.7%)
Jun 2024
-
$2.46B(+7.6%)
$9.67B(+0.1%)
Mar 2024
-
$2.29B(-4.0%)
$9.66B(-1.8%)
Dec 2023
$9.84B(-3.3%)
$2.39B(-5.7%)
$9.84B(-1.6%)
Sep 2023
-
$2.53B(+3.0%)
$9.99B(+0.2%)
Jun 2023
-
$2.46B(-0.3%)
$9.97B(-1.3%)
Mar 2023
-
$2.46B(-3.2%)
$10.10B(-0.7%)
Dec 2022
$10.17B(-7.4%)
$2.54B(+1.4%)
$10.17B(-1.8%)
Sep 2022
-
$2.51B(-3.1%)
$10.36B(-2.5%)
Jun 2022
-
$2.59B(+2.3%)
$10.63B(-1.7%)
Mar 2022
-
$2.53B(-7.4%)
$10.82B(-1.5%)
Dec 2021
$10.98B(-18.3%)
$2.73B(-1.6%)
$10.98B(-1.1%)
Sep 2021
-
$2.78B(+0.1%)
$11.10B(-5.1%)
Jun 2021
-
$2.77B(+3.0%)
$11.70B(-7.2%)
Mar 2021
-
$2.69B(-5.6%)
$12.60B(-6.3%)
Dec 2020
$13.44B(-6.5%)
$2.85B(-15.5%)
$13.44B(-5.7%)
Sep 2020
-
$3.38B(-8.3%)
$14.26B(-1.5%)
Jun 2020
-
$3.68B(+4.2%)
$14.49B(+0.4%)
Mar 2020
-
$3.53B(-3.7%)
$14.42B(+0.3%)
Dec 2019
$14.38B(+6.9%)
$3.67B(+2.0%)
$14.38B(+1.0%)
Sep 2019
-
$3.60B(-0.5%)
$14.23B(+1.1%)
Jun 2019
-
$3.62B(+3.6%)
$14.07B(+1.9%)
Mar 2019
-
$3.49B(-1.0%)
$13.81B(+2.7%)
Dec 2018
$13.45B(+9.6%)
$3.53B(+2.5%)
$13.45B(+1.7%)
Sep 2018
-
$3.44B(+2.5%)
$13.23B(+2.8%)
Jun 2018
-
$3.36B(+7.2%)
$12.87B(+2.2%)
Mar 2018
-
$3.13B(-5.3%)
$12.59B(+2.6%)
Dec 2017
$12.27B(+7.2%)
$3.31B(+7.4%)
$12.27B(+3.7%)
Sep 2017
-
$3.08B(-0.0%)
$11.84B(+1.0%)
Jun 2017
-
$3.08B(+9.5%)
$11.72B(+1.6%)
Mar 2017
-
$2.81B(-2.1%)
$11.53B(+0.7%)
Dec 2016
$11.45B(+6.4%)
$2.87B(-2.8%)
$11.45B(+0.3%)
Sep 2016
-
$2.96B(+2.1%)
$11.42B(+1.6%)
Jun 2016
-
$2.89B(+6.1%)
$11.24B(+2.8%)
Mar 2016
-
$2.73B(-4.0%)
$10.94B(+1.6%)
Dec 2015
$10.76B(+10.9%)
$2.84B(+2.2%)
$10.76B(+1.9%)
Sep 2015
-
$2.78B(+7.2%)
$10.57B(+2.6%)
Jun 2015
-
$2.59B(+1.4%)
$10.30B(+1.7%)
Mar 2015
-
$2.55B(-3.2%)
$10.13B(+4.4%)
Dec 2014
$9.70B(+40.0%)
$2.64B(+5.1%)
$9.70B(+7.5%)
Sep 2014
-
$2.51B(+3.7%)
$9.03B(+8.2%)
Jun 2014
-
$2.42B(+13.7%)
$8.34B(+9.1%)
Mar 2014
-
$2.13B(+8.3%)
$7.65B(+10.3%)
Dec 2013
$6.93B(+25.7%)
$1.97B(+7.6%)
$6.93B(+8.6%)
Sep 2013
-
$1.83B(+6.1%)
$6.38B(+7.4%)
Jun 2013
-
$1.72B(+21.8%)
$5.94B(+5.4%)
Mar 2013
-
$1.42B(-0.2%)
$5.64B(+2.2%)
Dec 2012
$5.52B(+9.3%)
$1.42B(+2.3%)
$5.52B(-10.5%)
Sep 2012
-
$1.39B(-2.5%)
$6.16B(+5.9%)
Jun 2012
-
$1.42B(+10.0%)
$5.82B(+3.8%)
Mar 2012
-
$1.29B(-37.5%)
$5.61B(+1.6%)
Dec 2011
$5.05B(+7.0%)
$2.07B(+98.0%)
$5.52B(+18.1%)
Sep 2011
-
$1.04B(-13.7%)
$4.67B(-2.8%)
Jun 2011
-
$1.21B(+0.4%)
$4.81B(-0.1%)
Mar 2011
-
$1.20B(-1.3%)
$4.81B(+2.0%)
Dec 2010
$4.72B(+7.7%)
$1.22B(+3.7%)
$4.72B(+2.0%)
Sep 2010
-
$1.18B(-3.0%)
$4.62B(+1.2%)
Jun 2010
-
$1.21B(+9.4%)
$4.57B(+2.7%)
Mar 2010
-
$1.11B(-1.6%)
$4.45B(+1.7%)
Dec 2009
$4.38B(+6.8%)
$1.13B(+0.6%)
$4.38B(+1.3%)
Sep 2009
-
$1.12B(+2.5%)
$4.32B(+0.6%)
Jun 2009
-
$1.09B(+5.5%)
$4.29B(+2.4%)
Mar 2009
-
$1.04B(-3.0%)
$4.19B(+2.3%)
Dec 2008
$4.10B(+29.2%)
$1.07B(-2.2%)
$4.10B(+4.5%)
Sep 2008
-
$1.09B(+10.0%)
$3.92B(+8.4%)
Jun 2008
-
$993.44M(+5.4%)
$3.62B(+6.5%)
Mar 2008
-
$942.19M(+5.5%)
$3.40B(+7.1%)
Dec 2007
$3.17B(+18.2%)
$893.30M(+13.2%)
$3.17B(+6.2%)
Sep 2007
-
$789.23M(+2.1%)
$2.99B(+3.0%)
Jun 2007
-
$773.18M(+8.0%)
$2.90B(+4.1%)
Mar 2007
-
$715.91M(+1.1%)
$2.79B(+3.9%)
Dec 2006
$2.68B(+56.6%)
$708.34M(+0.7%)
$2.68B(+41.3%)
Sep 2006
-
$703.49M(+6.6%)
$1.90B(+6.0%)
Jun 2006
-
$660.04M(+8.0%)
$1.79B(+3.1%)
Mar 2006
-
$611.17M(-903.9%)
$1.74B(+1.4%)
Dec 2005
$1.71B(+7.4%)
-$76.03M(-112.8%)
$1.71B(-2.7%)
Sep 2005
-
$596.21M(-1.6%)
$1.76B(+3.1%)
Jun 2005
-
$605.63M(+3.0%)
$1.71B(+4.1%)
Mar 2005
-
$587.80M(-2202.1%)
$1.64B(+2.9%)
Dec 2004
$1.60B
-$27.96M(-105.1%)
$1.60B(+11.6%)
Sep 2004
-
$543.28M(+0.8%)
$1.43B(+39.5%)
DateAnnualQuarterlyTTM
Jun 2004
-
$538.76M(-0.5%)
$1.03B(+68.0%)
Mar 2004
-
$541.74M(-380.4%)
$610.63M(+228.1%)
Dec 2003
$186.13M(-54.0%)
-$193.20M(-239.5%)
$186.13M(-398.4%)
Sep 2003
-
$138.53M(+12.1%)
-$62.37M(-171.3%)
Jun 2003
-
$123.56M(+5.4%)
$87.42M(-62.5%)
Mar 2003
-
$117.25M(-126.5%)
$233.13M(-42.3%)
Dec 2002
$404.22M(-61.2%)
-$441.71M(-253.2%)
$404.22M(-64.1%)
Sep 2002
-
$288.33M(+7.1%)
$1.13B(+2.1%)
Jun 2002
-
$269.26M(-6.6%)
$1.10B(+0.8%)
Mar 2002
-
$288.34M(+3.2%)
$1.09B(+4.9%)
Dec 2001
$1.04B(+12.6%)
$279.41M(+5.4%)
$1.04B(+3.5%)
Sep 2001
-
$265.19M(+1.8%)
$1.01B(+3.2%)
Jun 2001
-
$260.58M(+9.9%)
$975.93M(+3.2%)
Mar 2001
-
$237.05M(-3.1%)
$945.86M(+2.2%)
Dec 2000
$925.66M(+16.5%)
$244.55M(+4.6%)
$925.66M(+2.1%)
Sep 2000
-
$233.75M(+1.4%)
$906.45M(+2.9%)
Jun 2000
-
$230.51M(+6.3%)
$881.10M(+5.0%)
Mar 2000
-
$216.85M(-3.8%)
$839.51M(+5.7%)
Dec 1999
$794.43M(+42.5%)
$225.34M(+8.1%)
$794.38M(+7.7%)
Sep 1999
-
$208.40M(+10.3%)
$737.44M(+9.3%)
Jun 1999
-
$188.93M(+10.0%)
$674.94M(+9.8%)
Mar 1999
-
$171.72M(+2.0%)
$614.81M(+10.3%)
Dec 1998
$557.59M(+28.5%)
$168.39M(+15.4%)
$557.59M(+4.2%)
Sep 1998
-
$145.90M(+13.3%)
$535.34M(+9.2%)
Jun 1998
-
$128.80M(+12.5%)
$490.04M(+8.0%)
Mar 1998
-
$114.50M(-21.7%)
$453.64M(+4.5%)
Dec 1997
$434.04M(+56.6%)
$146.14M(+45.3%)
$433.94M(+10.5%)
Sep 1997
-
$100.60M(+8.9%)
$392.59M(+1.0%)
Jun 1997
-
$92.40M(-2.5%)
$388.79M(+15.2%)
Mar 1997
-
$94.80M(-9.5%)
$337.59M(+21.8%)
Dec 1996
$277.09M(+82.7%)
$104.79M(+8.3%)
$277.19M(+22.9%)
Sep 1996
-
$96.80M(+135.0%)
$225.49M(+38.7%)
Jun 1996
-
$41.20M(+19.8%)
$162.59M(+5.5%)
Mar 1996
-
$34.40M(-35.2%)
$154.09M(+1.6%)
Dec 1995
$151.69M(-3.0%)
$53.09M(+56.6%)
$151.69M(+7.2%)
Sep 1995
-
$33.90M(+3.7%)
$141.54M(+1.5%)
Jun 1995
-
$32.70M(+2.2%)
$139.44M(-0.1%)
Mar 1995
-
$32.00M(-25.5%)
$139.54M(-6.2%)
Dec 1994
$156.34M(+14.6%)
$42.94M(+35.0%)
$148.74M(+5.5%)
Sep 1994
-
$31.80M(-3.0%)
$141.00M(-1.5%)
Jun 1994
-
$32.80M(-20.4%)
$143.10M(-1.3%)
Mar 1994
-
$41.20M(+17.0%)
$145.00M(+6.4%)
Dec 1993
$136.40M(+10.3%)
$35.20M(+3.8%)
$136.30M(-10.7%)
Sep 1993
-
$33.90M(-2.3%)
$152.60M(-2.6%)
Jun 1993
-
$34.70M(+6.8%)
$156.60M(+11.9%)
Mar 1993
-
$32.50M(-36.9%)
$140.00M(+13.3%)
Dec 1992
$123.70M(+101.5%)
$51.50M(+35.9%)
$123.60M(+41.3%)
Sep 1992
-
$37.90M(+109.4%)
$87.50M(+35.9%)
Jun 1992
-
$18.10M(+12.4%)
$64.40M(+4.5%)
Mar 1992
-
$16.10M(+4.5%)
$61.60M(+0.3%)
Dec 1991
$61.40M(+22.6%)
$15.40M(+4.1%)
$61.40M(+2.7%)
Sep 1991
-
$14.80M(-3.3%)
$59.80M(+4.0%)
Jun 1991
-
$15.30M(-3.8%)
$57.50M(+6.1%)
Mar 1991
-
$15.90M(+15.2%)
$54.20M(+8.2%)
Dec 1990
$50.10M(+75.8%)
$13.80M(+10.4%)
$50.10M(+14.4%)
Sep 1990
-
$12.50M(+4.2%)
$43.80M(+14.4%)
Jun 1990
-
$12.00M(+1.7%)
$38.30M(+15.4%)
Mar 1990
-
$11.80M(+57.3%)
$33.20M(+12.5%)
Dec 1989
$28.50M(+38.3%)
$7.50M(+7.1%)
$29.50M(+6.9%)
Sep 1989
-
$7.00M(+1.4%)
$27.60M(+14.0%)
Jun 1989
-
$6.90M(-14.8%)
$24.20M(+4.8%)
Mar 1989
-
$8.10M(+44.6%)
$23.10M(+12.1%)
Dec 1988
$20.60M(+139.5%)
$5.60M(+55.6%)
$20.60M(+22.6%)
Sep 1988
-
$3.60M(-37.9%)
$16.80M(+12.0%)
Jun 1988
-
$5.80M(+3.6%)
$15.00M(+37.6%)
Mar 1988
-
$5.60M(+211.1%)
$10.90M(+28.2%)
Dec 1987
$8.60M(+34.4%)
$1.80M(0.0%)
$8.50M(+13.3%)
Sep 1987
-
$1.80M(+5.9%)
$7.50M(+17.2%)
Jun 1987
-
$1.70M(-46.9%)
$6.40M(-4.5%)
Mar 1987
-
$3.20M(+300.0%)
$6.70M(+6.3%)
Dec 1986
$6.40M(-57.6%)
$800.00K(+14.3%)
$6.30M(-25.0%)
Sep 1986
-
$700.00K(-65.0%)
$8.40M(-28.2%)
Jun 1986
-
$2.00M(-28.6%)
$11.70M(-20.9%)
Mar 1986
-
$2.80M(-3.4%)
$14.80M(-1.3%)
Dec 1985
$15.10M(-34.1%)
$2.90M(-27.5%)
$15.00M(-21.9%)
Sep 1985
-
$4.00M(-21.6%)
$19.20M(-9.0%)
Jun 1985
-
$5.10M(+70.0%)
$21.10M(-2.8%)
Mar 1985
-
$3.00M(-57.7%)
$21.70M(-5.2%)
Dec 1984
$22.90M
$7.10M(+20.3%)
$22.90M(+44.9%)
Sep 1984
-
$5.90M(+3.5%)
$15.80M(+59.6%)
Jun 1984
-
$5.70M(+35.7%)
$9.90M(+135.7%)
Mar 1984
-
$4.20M
$4.20M

FAQ

  • What is Biogen annual revenue?
  • What is the all time high annual revenue for Biogen?
  • What is Biogen annual revenue year-on-year change?
  • What is Biogen quarterly revenue?
  • What is the all time high quarterly revenue for Biogen?
  • What is Biogen quarterly revenue year-on-year change?
  • What is Biogen TTM revenue?
  • What is the all time high TTM revenue for Biogen?
  • What is Biogen TTM revenue year-on-year change?

What is Biogen annual revenue?

The current annual revenue of BIIB is $9.68B

What is the all time high annual revenue for Biogen?

Biogen all-time high annual revenue is $14.38B

What is Biogen annual revenue year-on-year change?

Over the past year, BIIB annual revenue has changed by -$159.70M (-1.62%)

What is Biogen quarterly revenue?

The current quarterly revenue of BIIB is $2.45B

What is the all time high quarterly revenue for Biogen?

Biogen all-time high quarterly revenue is $3.68B

What is Biogen quarterly revenue year-on-year change?

Over the past year, BIIB quarterly revenue has changed by -$11.10M (-0.45%)

What is Biogen TTM revenue?

The current TTM revenue of BIIB is $9.68B

What is the all time high TTM revenue for Biogen?

Biogen all-time high TTM revenue is $14.49B

What is Biogen TTM revenue year-on-year change?

Over the past year, BIIB TTM revenue has changed by +$68.40M (+0.71%)
On this page